2m 2m 2m 2m 2m 2m 2m
PHIO PHARMA (PHIO)
NASDAQ
$1.19+$0.005 (+0.42%)
Price as of Aug 21, 2026 7:58 PM EDT- $13.7MMarket Cap
- -43.54%1-Year Change
- BiotechnologyIndustry
PHIO PHARMA (PHIO)
$1.19+$0.005 (+0.42%)
PHIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.18 | ||
Change | -$0.03 (-2.48%) | ||
Open | $1.24 | ||
High | $1.24 | ||
Low | $1.17 | ||
Previous Close | $1.21 | ||
Volume | 138,318 | ||
30-Day Average Volume | 148,116 | ||
1-Week Change | 8.26% | ||
1-Month Change | 4.42% | ||
1-Year Change | -43.54% | ||
3-Year Change | -94.63% | ||
5-Year Change | -99.35% | ||
Fundamentals | |||
Shares Outstanding | 11.6M | ||
Total Assets | $14.3M | ||
Market Cap | $13.7M | ||
Enterprise Value | $712,355.00 | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$4.1M | ||
Free Cash Flow | -$4.0M | ||
EBIT | -$4.1M | ||
EBITDA | -$4.1M | ||
Net Working Capital | $12.6M | ||
EPS | -$0.36 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -3 | ||
PEG | 1 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 9 | ||
Last Split Date | 07/05/2024 | ||
Earnings & Revenue